Search research articles
Contact Us
Filters
Showing results (11-20 of 671) with videos related to
Page
of 68
Sort By:
Oncology (Williston Park, N.Y.)
|
February 3, 2005
Epidermal growth factor receptor inhibitors and colorectal cancer
Jeffrey A Meyerhardt, Charles S Fuchs
Nature Clinical Practice. Oncology
|
November 3, 2005
Do cyclo-oxygenase 2 inhibitors increase the risk of cardiovascular events?
Andrew T Chan, Charles S Fuchs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study
Charles S Fuchs, John Marshall, José Barrueco
Expert Review of Molecular Diagnostics
|
August 1, 2012
How many molecular subtypes? Implications of the unique tumor principle in personalized medicine
Shuji Ogino, Charles S Fuchs, Edward Giovannucci
Journal of the National Cancer Institute
|
June 7, 2015
Response
Kimmie Ng, Andrew T Chan, Charles S Fuchs
The New England Journal of Medicine
|
May 25, 2007
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
Andrew T Chan, Shuji Ogino, Charles S Fuchs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Sign of Leser-Trélat in newly diagnosed advanced gastric adenocarcinoma
Akash Nanda, Harvey J Mamon, Charles S Fuchs
Gastroenterology
|
July 16, 2008
Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression
Eva S Schernhammer, Shuji Ogino, Charles S Fuchs
JAMA
|
August 13, 2009
Aspirin use and survival after diagnosis of colorectal cancer
Andrew T Chan, Shuji Ogino, Charles S Fuchs
Cancer Journal (Sudbury, Mass.)
|
July 11, 2007
Adjuvant and neoadjuvant approaches in gastric cancer
Kimmie Ng, Jeffrey A Meyerhardt, Charles S Fuchs
Page
of 68
Search research articles
Search
Showing results (11-20 of 671) with videos related to
Sort By:
Page
of 68
Oncology (Williston Park, N.Y.)
|
February 3, 2005
Epidermal growth factor receptor inhibitors and colorectal cancer
Jeffrey A Meyerhardt, Charles S Fuchs
Nature Clinical Practice. Oncology
|
November 3, 2005
Do cyclo-oxygenase 2 inhibitors increase the risk of cardiovascular events?
Andrew T Chan, Charles S Fuchs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study
Charles S Fuchs, John Marshall, José Barrueco
Expert Review of Molecular Diagnostics
|
August 1, 2012
How many molecular subtypes? Implications of the unique tumor principle in personalized medicine
Shuji Ogino, Charles S Fuchs, Edward Giovannucci
Journal of the National Cancer Institute
|
June 7, 2015
Response
Kimmie Ng, Andrew T Chan, Charles S Fuchs
The New England Journal of Medicine
|
May 25, 2007
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
Andrew T Chan, Shuji Ogino, Charles S Fuchs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Sign of Leser-Trélat in newly diagnosed advanced gastric adenocarcinoma
Akash Nanda, Harvey J Mamon, Charles S Fuchs
Gastroenterology
|
July 16, 2008
Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression
Eva S Schernhammer, Shuji Ogino, Charles S Fuchs
JAMA
|
August 13, 2009
Aspirin use and survival after diagnosis of colorectal cancer
Andrew T Chan, Shuji Ogino, Charles S Fuchs
Cancer Journal (Sudbury, Mass.)
|
July 11, 2007
Adjuvant and neoadjuvant approaches in gastric cancer
Kimmie Ng, Jeffrey A Meyerhardt, Charles S Fuchs
Page
of 68